Boost commercialisation to beat microbes – report
Boosting pathways to commercialisation is seen as part of the answer to challenges Australia needs to overcome to avoid being thrust back into a pre-antimicrobial age where simple infections are deadly and some surgeries are too risky to perform. Antimicrobial resistance (AMR) – when bacteria and other microbes become resistant to the drugs designed to…
Details










